Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | December 11, 2024 |
| PDB ID ▼ | UniProt ID | Title | Descriptor |
|---|---|---|---|
| 6MVL | Q9H7M9 | Crystal structure of VISTA bound to a pH-selective antibody Fab fragment | |
| 6MVL | 6MVL | Crystal structure of VISTA bound to a pH-selective antibody Fab fragment | |
| 6MVJ | Q1K5M0 | Cellobiose complex Cel45A from Neurospora crassa OR74A | |
| 6MVD | P04180 | Crystal structure of Lecithin:cholesterol acyltransferase (LCAT) in complex with isopropyl dodec-11-enylfluorophosphonate (IDFP) and a small molecule activator | |
| 6MUG | B3UEZ6 | Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-386150 in Complex with Human Antibodies 3H109L and 35O22 at 3.8 Angstrom | |
| 6MUG | 6MUG | Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-386150 in Complex with Human Antibodies 3H109L and 35O22 at 3.8 Angstrom | |
| 6MUG | B3UES2 | Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-386150 in Complex with Human Antibodies 3H109L and 35O22 at 3.8 Angstrom | |
| 6MUF | B3UEZ6 | Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer in Complex with Human Antibodies 3H109L and 35O22 at 3.4 Angstrom | |
| 6MUF | 6MUF | Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer in Complex with Human Antibodies 3H109L and 35O22 at 3.4 Angstrom | |
| 6MUF | B3UES2 | Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer in Complex with Human Antibodies 3H109L and 35O22 at 3.4 Angstrom | |
| 6MUB | P0DOX5 | Anti-HIV-1 Fab 2G12 + Man5 re-refinement | |
| 6MUB | 6MUB | Anti-HIV-1 Fab 2G12 + Man5 re-refinement | |
| 6MUB | P0DOX5 | Anti-HIV-1 Fab 2G12 + Man5 re-refinement | |
| 6MUB | 6MUB | Anti-HIV-1 Fab 2G12 + Man5 re-refinement | |
| 6MUB | P0DOX7 | Anti-HIV-1 Fab 2G12 + Man5 re-refinement | |
| 6MUB | P0DOX7 | Anti-HIV-1 Fab 2G12 + Man5 re-refinement | |
| 6MU8 | Q2N0S6 | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-386150 in Complex with Human Antibodies 3H109L and 35O22 at 3.5 Angstrom | |
| 6MU8 | 6MU8 | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-386150 in Complex with Human Antibodies 3H109L and 35O22 at 3.5 Angstrom | |
| 6MU7 | Q2N0S6 | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-818251 in Complex with Human Antibodies 3H109L and 35O22 at 3.1 Angstrom | |
| 6MU7 | 6MU7 | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-818251 in Complex with Human Antibodies 3H109L and 35O22 at 3.1 Angstrom | |
| 6MU6 | Q2N0S6 | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-814508 in Complex with Human Antibodies 3H109L and 35O22 at 3.2 Angstrom | |
| 6MU6 | 6MU6 | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-814508 in Complex with Human Antibodies 3H109L and 35O22 at 3.2 Angstrom | |
| 6MU3 | P0DOX5 | Anti-HIV-1 Fab 2G12 + Man7 re-refinement | |
| 6MU3 | 6MU3 | Anti-HIV-1 Fab 2G12 + Man7 re-refinement | |
| 6MU3 | P0DOX5 | Anti-HIV-1 Fab 2G12 + Man7 re-refinement | |
| 6MU3 | 6MU3 | Anti-HIV-1 Fab 2G12 + Man7 re-refinement | |
| 6MU3 | P0DOX7 | Anti-HIV-1 Fab 2G12 + Man7 re-refinement | |
| 6MU3 | P0DOX7 | Anti-HIV-1 Fab 2G12 + Man7 re-refinement | |
| 6MU0 | P47636 | Crystal Structure of Ribose-5-phosphate Isomerase B from Mycoplasma genitalium with bound Ribulose-5-phosphate | |
| 6MTW | Q8NCC3 | Lysosomal Phospholipase A2 in complex with Zinc | |
| 6MTN | Q2N0S6 | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor Compound 484 in Complex with Human Antibodies 3H109L and 35O22 at 3.0 Angstrom | |
| 6MTN | 6MTN | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor Compound 484 in Complex with Human Antibodies 3H109L and 35O22 at 3.0 Angstrom | |
| 6MTJ | Q2N0S6 | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-378806 in Complex with Human Antibodies 3H109L and 35O22 at 2.9 Angstrom | |
| 6MTJ | 6MTJ | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-378806 in Complex with Human Antibodies 3H109L and 35O22 at 2.9 Angstrom | |
| 6MSY | P0DOX5 | Anti-HIV-1 Fab Fab 2G12 + Man4 re-refinement | |
| 6MSY | 6MSY | Anti-HIV-1 Fab Fab 2G12 + Man4 re-refinement | |
| 6MSY | P0DOX5 | Anti-HIV-1 Fab Fab 2G12 + Man4 re-refinement | |
| 6MSY | 6MSY | Anti-HIV-1 Fab Fab 2G12 + Man4 re-refinement | |
| 6MSY | P0DOX7 | Anti-HIV-1 Fab Fab 2G12 + Man4 re-refinement | |
| 6MSY | P0DOX7 | Anti-HIV-1 Fab Fab 2G12 + Man4 re-refinement | |
| 6MSU | P06756 | Integrin alphaVBeta3 in complex with EETI-II 2.5F | |
| 6MSU | P05106 | Integrin alphaVBeta3 in complex with EETI-II 2.5F | |
| 6MSU | 6MSU | Integrin alphaVBeta3 in complex with EETI-II 2.5F | |
| 6MSS | 6MSS | Diversity in the type II Natural Killer T cell receptor repertoire and antigen specificity leads to differing CD1d docking strategies | |
| 6MSS | P11609 | Diversity in the type II Natural Killer T cell receptor repertoire and antigen specificity leads to differing CD1d docking strategies | |
| 6MSS | P01887 | Diversity in the type II Natural Killer T cell receptor repertoire and antigen specificity leads to differing CD1d docking strategies | |
| 6MSL | P06756 | Integrin AlphaVBeta3 ectodomain bound to EETI-II 2.5D | |
| 6MSL | P05106 | Integrin AlphaVBeta3 ectodomain bound to EETI-II 2.5D | |
| 6MSL | 6MSL | Integrin AlphaVBeta3 ectodomain bound to EETI-II 2.5D | |
| 6MRV | 6MRV | Sialidase26 co-crystallized with DANA |
